Yüklüyor......
KIF11 is upregulated in colorectal cancer and silencing of it impairs tumor growth and sensitizes colorectal cancer cells to oxaliplatin via p53/GSK3β signaling
Colorectal cancer (CRC) is the most frequently diagnosed cancer of the digestive tract. Chemotherapy drugs such as oxaliplatin are frequently administered to CRC patients diagnosed with advanced or metastatic disease. A deep understanding of the molecular mechanism underlying CRC tumorigenesis and i...
Kaydedildi:
| Yayımlandı: | J Cancer |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Ivyspring International Publisher
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8120193/ https://ncbi.nlm.nih.gov/pubmed/33995648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.52103 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|